Biological Evaluation (Antidabetics Activity) of Methanolic Extract of Achyranthes Aspera Leaves

Main Article Content

Sachin Kumar Agrahari
M.K. Gupta

Abstract

Diabetes mellitus, or simply diabetes, is a common name for a group of metabolic diseases that impair the body's capacity to maintain normal levels of blood sugar (glucose). Since glucose is used by cells for energy, maintaining steady blood glucose levels is essential for health. In diabetes mellitus, either insulin synthesis or insulin action is impaired, or both, leading to persistently high blood sugar levels (hyperglycemia). It's among the top five killers anywhere in the globe. The number of individuals with diabetes is expected to quadruple by 2030, from the current 150 million, which is already roughly five times greater than forecasts from a decade ago. By 2025, an estimated 57.2 million people in India would have diabetes. Significant progress in the discovery of effective medicinal therapies has been made with the help of plants. About 80% of people in underdeveloped countries use traditional medicine as their major source of treatment, according a report by the World Health Organisation (WHO). Many of the medications used in contemporary medicine have their origins in the study of herbs. There are thought to be between 250,000 and 400,000 different kinds of plants, although only around 15% have been formally researched by scientists for their biological activities. This emphasises the significance of phyto-pharmacological research into the systematic and directed assessment of herbal medicines.This investigation set out to determine whether or not Achyranthes aspera (also known as Apamargam) might reduce blood sugar levels in rats with streptozotocin-induced hyperglycemia. Streptozotocin-induced diabetic rats were used to test the in-vivo anti-diabetic activity of a methanolic extract of Achyranthes aspera leaves. Beta-cells, which produce insulin, are targeted for elimination by streptozotocin. Glucose levels in the blood rise after being treated with streptozotocin because insulin production drops. However, the aqueous extract showed a substantial decrease in blood glucose levels when used in therapy.

Article Details

How to Cite
Sachin Kumar Agrahari, & M.K. Gupta. (2023). Biological Evaluation (Antidabetics Activity) of Methanolic Extract of Achyranthes Aspera Leaves. Journal of Coastal Life Medicine, 11(2), 573–576. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1050
Section
Articles

References

Davis, S.N (2006). “Insulin, Oral Hypoglycemic Agents and the Pharmacology of the Endocrine Pancreas”, First Edition, McGraw-Hill, New York, pp.1613-1645.

Bailey C.J (2001) Current Diabetes Reports, 1: 1194-126.

Rastogi, M (1990). “Compendium of Indian medicinal plants”, First Edition, New Delhi, pp. 131-142.

Madhava, C.K., K. Sivaji, K.T. Rao (2008). “Flowering Plants of Chittoor district”, Second Edition, Students offset printers, Tirupati, pp. 1354-1456.

Rout S.D., T. Panda & N. Mishra (2008) Studies on Ethno-Medicine, 3: 27-32.

Goyal, R.K. & B.S. Shah (2001). “Practical in Pharmacognosy”, Fifth Edition, Nirali Prakashan, Pune, pp. 128-55.

Rangari, V.D (2004). “Pharmacognosy and Phytochemistry”, First Edition, Nashik, Career publication, pp.129-50.

Khandelwal, K.R (2003). “Practical pharmacognosy”, Tenth Edition, Nirali Prakashan, Pune, pp.38-161.

Mohammed B., Z. Fathima, Z. Abder, M. Hassane, A. Mohammed & L. Adelkhaleq (2003) Fitoterapia, 74: 677-681.

Sabu R.K (2004) Indian Journal of Physiology and Pharmacology, 48: 81-88.

Hnatyszyn O., J. Mino, G. Ferraro & C. Acevedo (2002) Phytomedicine, 9: 556-559.